Image courtesy of ImaCor
January 16, 2015 — ImaCor Inc. will be showcasing for the first time Zura EVO1, its all-in-one platform for advanced hemodynamic management, at three annual scientific meetings: EAST (Eastern Association for the Surgery of Trauma), SCCM (Society of Critical Care Medicine) and STS (Society of Thoracic Surgeons). The new capabilities are imaging features at 7 MHz and 18 cm depth, hemodynamic trending data of cardiac filling and function and availability of a transthoracic echocardiography (TTE) probe for complementary hemodynamic management.
ImaCor’s all-in-one hemodynamic management platform offers hTEE, which is enabled by a miniaturized, disposable probe that can be left indwelling for up to 72 hours of direct continuous visualization. Most recently, a retrospective analysis at St. George’s Healthcare NHS Trust in London demonstrated that 195 hTEE evaluations resulted in the change in therapy of 41 patients, which ultimately improved hemodynamic parameters in 80.5% of patients. RV failure was diagnosed in almost 70% of patients, of which hTEE had a direct therapeutic impact in 68 percent. The study is available online at the Journal of Cardiothoracic and Vascular Anesthesia.
For more information: www.imacorinc.com